ZCZC
BSS-46
PFIZER-VACCINE-AUTHORIZATION-BANGLADESH
Bangladesh approves emergency use of Covid-19 Pfizer vaccine
DHAKA, May 27, 2021 (BSS) – The Directorate General of Drug Administration (DGDA) today approved emergency use of Pfizer mRNA Covid-19 vaccine in the country.
The regulator has given Emergency Use Authorization ( EUA) after all necessary examinations by the committee, a press release, signed by Maj Gen Md Mahbubur Rahman, Director General of DGDA said.
Produced by Pfizer Manufacturing Belgium NV, this is the fourth Covid-19 vaccine approved for emergency use in Bangladesh.
The other approved vaccines are: Covishield produced by Serum Institute of India, Sputnik V produced by Generium Joint Stock Company of Russia, and Sinopharm produced by Beijing Institute of Biological Products Co. Ltd of China.
BSS/PR/MMR/ARS/2005 HRS